The role of growth factors in inhibition of collagen degeneration and chondrocyte differentiation in patients with osteoarthrosis

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 9, 2008, Pages 40-45

  Chetina, E V ^a   Poole, A R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; RNA; SIGNAL PEPTIDE;

AGED; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; RNA;

EID: 58149515746     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. th ed. Philadelphia; Lippincott, Williams & Wilkins, 2005. 223-269.
2. Billinghurst R. C., Dahlberg L., Ionescu M. et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartiliage. J. Clin. Invest. 1997; 99 (7): 1534-1545.
3. 2 modulates cartilage proteoglycan degradation in human oateoarthritic explants. Arthr. and Rheum. 2002; 46 (7): 1789-1803.
4. Pelletier J. P., Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J. Rheumatol. 1989; 18 (1, suppl.): 19-27.
5. von der Mark K., Kirsch T., Nerlich A. et al. Type X collagen in human osteoarthritic cartilage - indication of chondrocyte hypertrophy. Arthr. and Rheum. 1992; 35 (7): 806-811.
6. Aigner T., Berting W., Stoss H. Independent expression of fibril-forming collagens I, II and III in chondrocytes in human osteoarthritic cartilage. J. Clin. Invest. 1993; 91 (3): 829-837.
7. Tchetina E. V., Squires G., Poole A. R. Increased type II collagen degradation and very early focal cartilage degeneration is associated with the upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J. Rheumatol. 2005; 32 (5): 876-886.
8. Tchetina E. V., Mwale F., Poole A. R. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodelling, and cell differentiation. J. Bone Miner. Res. 2003: 18 (5) 844-851.
9. Mwale F., Tchetina E., Wu W., Poole A. R. The assembly and remodelling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IV and proteoglycan. J. Bone Miner. Res. 2002; 17 (2): 275-283.
10. Wu W., Tchetina E., Mwale F. et al. Proteolysis involving MMP-13 (collagenase-3) and the expression of the chondrocyte hypertrophic phenotype. J. Bone Miner. Res. 2002; 17 (4): 639-651.
11. Aigner T., McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol. Life Sci. 2002; 59 (1): 5- 18.
12. Bohme K., Winterhalter K. H., Bruckner P. Terminal differentiation of chondrocytes is a spontaneous process and is arrested by transforming growth factor-beta-2 and basic fibroblast growth factor in synergy. Exp. Cell Res. 1995: 216(1): 191-198.
13. Szuts V., Mollers U., Bittner K. et al. Terminal differentiation of chondrocytes is arrested at distinct stages identified by their expression repertoire of marker genes. Matrix Biol. 1998; 17 (6): 435-448.
14. Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthr. and Rheum. 1986; 29 (8): 1039-1149.
15. Farndale R. W., Buttle G. J., Barrett A J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylamethylene blue. Biochim. Biophys. Acta 1986: 883 (2): 173-177.
16. Karaplis A. C., Luz J., Gowacki J. et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid-hormone-related peptide gene. Genes Dev. 1994: 8 (3): 277-289.
17. 2/Smad signals repress chondrocyte hypertrophic differention and are required for maintaining articular cartilage. J. Cell Biol. 2001; 153 (91): 35-46.
18. Sanford L. P., Ormsby I., Gittenberger-de Groot A. C. et al. TGFβ2 knockout mice hane multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 1997; 124 (13): 2659-2670.
19. Verdier M.-P., Seite S., Guntzer K. et al. Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol. Int. 2005; 25 (2): 188-124.
20. Elford P. R., Graeber M., Ohtsu H. et al. Induction of swelling, synovial hyperhlasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor-β2 in the rabbit. Cytokine 1992; 4 (3): 232-238.
21. Kobayashi M., Squires G. R., Mousa A. et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthr. and Rheum. 2005; 52 (1): 128-135.
22. Aoyama T, Liang B., Okamoto T. et al. PGE2 signal through EP2 promotes the growth of articular chondrocytes. J. Bone Miner. Res. 2005: 20 (3): 377-389.
23. Li T.-F., Zuscik M. J., Lonescu A. M. et al. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp. Cell Res. 2004; 300 (1): 159-169.
24. Zhang X., Ziran N., Goater J. J. et al. Primary murine limb bud mesenchimal cells in longterm culture complete chondrocyte differentiation: TGF-β delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 2004; 34 (5): 809-817.